Verve Therapeutics might need to dilute shares significantly...
Verve Therapeutics might need to dilute shares significantly if it needs to cover another year's operations due to the 26% burn rate. The cash burn situation is worth monitoring for shareholders.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
STD0313 : What......never knew AI could also be a shill
STD0313 : Do better research. it drop on two heart attacks, one fatal in the study ( all participants were already end of life high risk)